ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichEndogena Therapeutics AG
Endogena Therapeutics AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Endogena Therapeutics is the development of therapies to repair damaged tissue by activating the body's own regenerative capabilities. To achieve this, the company combines artificial intelligence with years of experience in drug development to identify small molecules that can specifically activate the body's own stem cells. A key focus is on the development of therapies for inherited blindness and other degenerative diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Endogena Therapeutics AG

✓ Offered4
Development of endogenous regenerative medicines
Development of first-in-class endogenous regenerative drugs for the repair and regeneration of tissues and organs, based on small molecules and selective activation of endogenous cells.
Drug discovery and development for degenerative diseases
Drug discovery and development with a focus on indications with a high unmet medical need, in particular degenerative diseases related to aging and genetic disorders.
Development of therapies for retinal diseases
Development of therapeutic approaches for degenerative eye diseases, in particular retinitis pigmentosa and age-related macular degeneration, with clinical development and studies.
Development of therapies for idiopathic pulmonary fibrosis
Development of a drug program for idiopathic pulmonary fibrosis, a chronic, progressive lung disease with a high unmet medical need.
Trust & reputation

ranQ Trust Score of Endogena Therapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Endogena Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Endogena Therapeutics AG scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Endogena Therapeutics AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Endogena Therapeutics AG scores 52.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.85.74%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.20.04%
Qualifications+0.00

Endogena Therapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

February 16, 2024Media
Schweizer Forscher macht Blinde sehend
blick.ch
November 28, 2022Media
Neue Wege im Kampf ums Augenlicht
blick.ch

Knowledge

No knowledge articles yet

Once Endogena Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Endogena Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Endogena Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Endogena Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Binzmühlestrasse 170d
8050 Zurich

At a glance

Legal form
Corporation
UID
CHE-243.507.320
Founded
2020 · 6 years
Last commercial register change
August 13, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AI
    Acino International AG
    Zurich
    NN
    Novo Nordisk Health Care AG
    Zürich
    NN
    Novo Nordisk Pharma AG
    Zürich
    AA
    Athebio AG
    Schlieren
    OS
    OrPha Swiss GmbH
    Küsnacht Zh
    PA
    Philochem AG
    Otelfingen
    MA
    Mabylon AG
    Schlieren
    AT
    Amicus Therapeutics Switzerland GmbH
    Zurich